Parkinson's Australia promotes the best possible quality of life for people with Parkinson’s.  This section provides evidence-based research to the Parkinson’s community on symptom management, and better care options for living well.  

21 May 2020

The US Food & Drug Administration have approved Apomorphine Hydrochloride for use in the US as an on-demand sublingual treatment for off episodes in people with Parkinson's.

17 May 2020

A great study from overseas. If needed, please use the English translation

16 May 2020

Iron disorders and their relationships with Parkinson's

1 / 2

Please reload

The content of this web site is intended to convey general educational information and should not be relied upon as a substitute for professional healthcare advice. 

© 2020 by Parkinson's Australia, PO Box 108, Deakin West, ACT 2600

ABN 46 011 714 078   

Parkinson's Australia Privacy Policy

Search this site